Fan Shu-ying, Ke Yuan-nan, Zeng Yu-jie, Wang Yong, Cheng Wen-li, Yang Jian-ru
Department of Cardiology, China-Japan Friendship Hospital of Ministry of Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100029, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Dec;33(12):1141-5.
To examine the effects of carvedilol on myocardial ischemia and reperfusion injury and on gap junctional intercellular communication (GJIC).
The left coronary artery was occluded for 30 min and reperfused for 4 h. The activity of creatine phosphokinase (CK), lactate dehydrogenase (LDH) and the infarct size were measured. Isolated buffer-perfused hearts were divided randomly into four groups, sham operation (SO), myocardial ischemia and reperfusion (IR), carvedilol (CV) and heptanol (a gap junctional inhibitor) (HT). The effect of carvedilol on GJIC was measured by a modification of Scrape-loading and dye transfer method, and the state of CX43 phosphorylation was evaluated by Western blot.
Compared with the SO group, Increased CK, LDH and infarct size were found in the IR group after 4 h reperfusion. GJIC in the IR group was not inhibited, but dephosphorylated CX43 was increased after 30 minutes of ischemia. Carvedilol decreased CK, LDH and infarct size compared with the IR rats; after 30 minutes of ischemia, both carvedilol and heptanol significantly reduced the GJIC, associated with a significant augmentation of dephosphorylated CX43.
These results suggest that carvedilol reduces GJIC during ischemia presumably by dephosphorylating Cx43, which may be one of the mechanisms of lessening myocardial ischemia-reperfusion injury.
研究卡维地洛对心肌缺血再灌注损伤及缝隙连接细胞间通讯(GJIC)的影响。
左冠状动脉闭塞30分钟后再灌注4小时。测定肌酸磷酸激酶(CK)、乳酸脱氢酶(LDH)活性及梗死面积。将离体缓冲灌注心脏随机分为四组:假手术组(SO)、心肌缺血再灌注组(IR)、卡维地洛组(CV)和庚醇组(一种缝隙连接抑制剂)(HT)。采用改良的刮擦加载和染料转移法测定卡维地洛对GJIC的影响,通过蛋白质印迹法评估CX43磷酸化状态。
与SO组相比,再灌注4小时后IR组CK、LDH升高,梗死面积增大。IR组GJIC未受抑制,但缺血30分钟后去磷酸化CX43增加。与IR大鼠相比,卡维地洛降低了CK、LDH及梗死面积;缺血30分钟后,卡维地洛和庚醇均显著降低GJIC,同时去磷酸化CX43显著增加。
这些结果表明,卡维地洛可能通过使Cx43去磷酸化而在缺血期间降低GJIC,这可能是减轻心肌缺血再灌注损伤的机制之一。